Nuvectis Pharma, Inc. (NVCT) vs Phathom Pharmaceuticals, Inc. (PHAT)
- Nuvectis Pharma, Inc. NVCT 18.48 −2.38%
- Phathom Pharmaceuticals, Inc. PHAT 6.92 −7.73%
Nuvectis Pharma, Inc. and Phathom Pharmaceuticals, Inc. are both Biotechnology companies. Nuvectis Pharma, Inc. and Phathom Pharmaceuticals, Inc. are of similar size ($618.0M and $606.8M). Nuvectis Pharma, Inc. has the higher net margin (0.00% vs −41.3%) and the higher return on invested capital (0.00% vs 0.00%). Across the 11 metrics below, Phathom Pharmaceuticals, Inc. leads on 6 and Nuvectis Pharma, Inc. on 5.
Valuation
Profitability
| Metric | NVCT | PHAT | Biotechnology median |
|---|---|---|---|
| Gross margin | — | 82.92% | 65.16% |
| Operating margin | 0.00% | (16.96%) | 0.00% |
| Net margin | 0.00% | (41.34%) | 0.00% |
| Free cash flow margin | 0.00% | (15.40%) | 0.00% |
| Return on equity | (233.30%) | 26.42% | (56.36%) |
| Return on assets | (122.61%) | (34.32%) | (48.04%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack